|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
Immucor (BLUD), based in Norcross, Georgia, sells reagents for blood testing to health care providers. Its revolutionary machine, the ABS2000, has been pending FDA approval for over a year and should have its application acted upon in the next few months. The ABS2000 automatically performs the basic 8 blood tests automatically, in much shorter time and at a great saving of lab technician time. Three blood samples are taken and the results are printed out or displayed by the machine's software.
The stock has been moving up strongly the past few weeks. Any comments?
|© 2021 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|